Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial-Reference-Cited by-同舟云学术

Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial

Published:2023-11-22 Issue: Volume: Page:
ISSN:0163-4984
Container-title:Biological Trace Element Research
language:en
Short-container-title:Biol Trace Elem Res

Author:

Ostadmohammadi Vahidreza,Namazi Mohammad Javad,Rezasoltani Mahsa,Kheirkhah Davood,Rajabi Mohammad,Sharif Alireza,Taghavi Ardakani Abbas,Raygan Fariba,Assareh Amelia A.,Sharif Mohammad Reza

Funder

Research deputy of Kashan University of Medical Sciences, Kashan, Iran

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12011-023-03954-z.pdf

Reference46 articles.

1. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U et al (2012) Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 54:700–713. https://doi.org/10.1097/MPG.0b013e318252a13f

2. Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R et al (2017) NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64:319–334. https://doi.org/10.1097/MPG.0000000000001482

3. Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A (2018) Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? Curr Vasc Pharmacol 16:219–227. https://doi.org/10.2174/1570161115666170621075619

4. Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P (2017) Non-alcoholic fatty liver disease: an update with special focus on the role of gut microbiota. Metabolism 71:182–197. https://doi.org/10.1016/j.metabol.2017.03.013

5. Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL et al (2022) Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol 13:880298. https://doi.org/10.3389/fimmu.2022.880298